Colloidal suspensions comprising a therapeutic agent and squalene
US8771746B2 · kind B2 · utility
1Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2009 |
| Grant date | Jul 8, 2014 |
| Priority date | — |
| Expiry date | Dec 5, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Colloidal suspensions comprising a therapeutic agent and squalene. Squalene binds to certain compounds, such as gacyclidine, much more tightly than other drug carriers, such as polylactic glycolic acid. Including squalene in the particulate phase sequesters the therapeutic agent and provides superior stability at room or body temperature.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.